| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 10918096 | Radiotherapy and Oncology | 2015 | 6 Pages |
Abstract
reRT + HT is an effective curative and palliative treatment option for patients with irresectable locoregional recurrent breast cancer in previously irradiated area. Early referral, treatment of chest wall recurrences ⩽5 cm in the absence of distant metastases, provided the highest local control rates. The cumulative effects of past and present treatments should be accounted for by adjusting treatment protocol to minimize toxicity.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
Sabine Oldenborg, Vanessa Griesdoorn, Rob van Os, Yoka H. Kusumanto, Bing S. Oei, Jack L. Venselaar, Paul J. Zum Vörde Sive Vörding, Martijn W. Heymans, Merel Willemijn Kolff, Coen R.N. Rasch, Hans Crezee, Geertjan van Tienhoven,